Draig Therapeutics
PrivateLast Round
Series B
Jul 14, 2026
Total Funding Raised
$205M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Draig Therapeutics is a biotechnology company that develops small molecule therapies for neuropsychiatric disorders, including major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Draig Therapeutics Comparables
Compare Draig Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Catalent | 65% | |
| Evonik Industries AG | 65% | |
| Implexis | 64% | |
Draig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 14, 2026 | ||||
| Series A | Jun 18, 2025 | ||||
| Seed | Sep 1, 2024 |
Key People
Founding team and executive leadership
Draig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B |
| SV Health Investors | Series A, Seed |
| Intermediate Capital Group | Series A |
| British Business Bank | Series B |
| Deep Track Capital | Series B |
| Jefferson Life Sciences | Series B |
| Canaan Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2026
$65M round led by Deep Track Capital.
- May 21, 2026
Monthly visitors increased 127% MoM, reaching 2.1K.
Draig Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Draig Therapeutics's valuation, stock price, and market status.